Structural basis of binding by cyclic nonphosphorylated peptide antagonists of Grb7 implicated in breast cancer

Nigus D Ambaye1, Stephanie C Pero, Menachem J Gunzburg

  • 1Department of Biochemistry and Molecular Biology, Monash University, Wellington Road, VIC 3800, Australia.

Insights

A novel peptide inhibitor, G7-18NATE, effectively blocks Growth-receptor-bound protein 7 (Grb7) in cancer cells. This study reveals its structural interaction and identifies improved analogues for potential Grb7-targeted cancer therapies.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Structural Biology

Background:

  • Growth-receptor-bound protein 7 (Grb7) is overexpressed in various cancers, correlating with erbB-2 receptor presence.
  • Grb7 promotes cancer progression by enhancing cell migration and proliferation.
  • Inhibiting Grb7 activity presents a therapeutic strategy for cancer treatment.

Purpose of the Study:

  • To elucidate the structural basis of G7-18NATE peptide inhibition of the Grb7 SH2 domain.
  • To identify and characterize novel Grb7 inhibitors with improved binding affinity.
  • To facilitate the development of second-generation Grb7-targeted therapeutics.

Main Methods:

  • X-ray crystallography to determine the Grb7-SH2 domain-G7-18NATE complex structure.
  • Phage display for identifying Grb7-SH2 binding peptide analogues.
  • Isothermal titration calorimetry to assess binding affinities of identified peptides.

Main Results:

  • The crystal structure reveals the specific interaction between G7-18NATE and the Grb7-SH2 domain.
  • Phage display identified G7-18NATE analogues with retained key amino acids (F2, G4, F9, YDN motif) and micromolar affinity.
  • Isothermal titration calorimetry confirmed similar or improved binding affinities for the novel analogues compared to G7-18NATE.

Conclusions:

  • The G7-18NATE peptide provides a structural foundation for Grb7 inhibition.
  • Optimized peptide analogues demonstrate enhanced binding to Grb7-SH2.
  • This research paves the way for developing effective Grb7-based cancer therapies.

Related Concept Videos

Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
GPCRs Regulate Adenylyl Cylase Activity01:09

GPCRs Regulate Adenylyl Cylase Activity

Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of cells.
Two...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...